Newsroom | 25965 results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes. Title of Security CUSIP Number(1) Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fix...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company’s 2025 fourth quarter common and preferred dividends. Ronald Marston’s Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Trilliant Health, the healthcare industry's leading analytics firm, today announced that its comprehensive hospital price transparency dataset is now publicly available in a single DuckDB data lake, eliminating the need for complex data pipelines and enabling instant comparative analysis across more than 5,000 hospitals nationwide. The release builds on Trilliant Health’s November update that centralized the individual hospital machine readable files (MRFs), m...

DUBLIN--(BUSINESS WIRE)--The "Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Exosome Therapeutics Market, valued at USD 32.63 Million in 2024, is projected to experience a CAGR of 41.56% to reach USD 262.58 Million by 2030. The market's expansion is fundamentally supported by an escalating understanding of exosome biology, the increasing prevalence of chronic and age-relat...

SAN MATEO, Califórnia--(BUSINESS WIRE)--O Baszucki Group anunciou hoje uma parceria com a Faculdade de Medicina da Universidade de Maryland para uma iniciativa de treinamento inovadora que ampliará a capacidade de oferecer terapia metabólica cetogênica na área de saúde mental. O programa, intitulado “LIVE IT~LAUNCH IT: Learning How to Implement and Use a Ketogenic Diet to Improve Mental Health in Your Patients For Health Care Workers” (em tradução livre: “VIVA ISSO E COLOQUE EM PRÁTICA: Aprende...

SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group and University of Maryland School of Medicine launch ketogenic metabolic therapy training for mental health clinicians....

SAN MATEO, California--(BUSINESS WIRE)--Baszucki Group oggi ha annunciato la sigla di una partnership con la University of Maryland School of Medicine per l’avvio di un’innovativa iniziativa formativa finalizzata a sviluppare competenze nella somministrazione della terapia metabolica chetogenica nell’ambito della salute mentale. Il programma, dal titolo “LIVE IT~LAUNCH IT: Learning How to Implement and Use a Ketogenic Diet to Improve Mental Health in Your Patients For Health Care Workers”, è di...

SAN MATEO, California--(BUSINESS WIRE)--Baszucki Group anunció hoy una colaboración con la Facultad de Medicina de la Universidad de Maryland para llevar a cabo una innovadora iniciativa de formación cuyo objetivo es desarrollar la capacidad para aplicar la terapia metabólica cetogénica en la atención de la salud mental. El programa, que lleva por título “LIVE IT~LAUNCH IT: Learning How to Implement and Use a Ketogenic Diet to Improve Mental Health in Your Patients For Health Care Workers” (Apr...

加州，聖馬提歐--(BUSINESS WIRE)--(美國商業資訊)-- Baszucki Group今天宣布與馬里蘭大學醫學院達成一項合作關係，雙方將推動一項創新培訓活動，促進心理健康領域應用生酮代謝療法。這項名為「LIVE IT~LAUNCH IT：醫護人員學習如何應用生酮飲食改善患者心理健康」的活動由Deanna Kelly博士（PharmD, BCPP、馬里蘭大學醫學院精神病學系William和Carol Carpenter精神疾病研究教授兼馬里蘭大學醫學院馬里蘭精神病學研究中心主任）主持，旨在教育並助力醫療保健提供者，引導他們採用這種介入性療法。其目標是培訓各類醫療保健專業人士，建立他們的信心，將這種前景可期的個人化代謝治療框架安全應用於臨床和研究領域。 越來越多的證據表明生酮代謝療法可有效治療包括精神分裂症、躁鬱症和重度憂鬱症在內的一系列嚴重精神疾病，包括史丹佛大學醫學院、愛丁堡大學和俄亥俄州立大學等機構的試點試驗。生酮代謝療法具有充任跨診斷性工具的潛力，正迅速崛起為一種有力的治療選擇。 然而，推廣生酮代謝療法仍存在重大障礙——大多數人缺乏生酮代謝療法的治療基礎設施。「由於...

カリフォルニア州サンマテオ--(BUSINESS WIRE)--（ビジネスワイヤ） -- Baszucki Groupは、精神医療におけるケトジェニック代謝療法の提供体制を構築する革新的なトレーニング計画に向けて、メリーランド大学医学部とパートナーシップを締結したと発表しました。本プログラム「LIVE IT〜LAUNCH IT：患者のメンタルヘルス改善を目的としたケトジェニック食の導入と活用方法を学ぶ、医療従事者向けプログラム」は、メリーランド大学医学部で精神疾患研究を担当するウィリアム・アンド・キャロル・カーペンター精神医学教授であり、メリーランド精神医学研究センター所長を務めるデアンナ・ケリー薬学博士（BCPP）が主導します。この取り組みは、医療従事者が自らこの介入法を実践することを通じて学び、必要な能力を身につけることを目的としています。これにより、多様な医療従事者が、この有望な個別化代謝治療の枠組みを臨床および研究の両現場で安全かつ自信を持って導入できるよう、必要な準備を整えることができます。 統合失調症、双極性障害、大うつ病性障害を含む重篤な精神疾患の幅広い領域におけるケト...